Clinical trial
Acute Respiratory Infections and Chronic Respiratory Disease Exacerbation Characterisation and Personalised Treatment Platform Study 2
NCT07029672 is registered in ClinicalTrials.gov with Manchester University NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acute Respiratory Infections and Chronic Respiratory Disease Exacerbation Characterisation and Personalised Treatment Platform Study 2
- Lead sponsor
- Manchester University NHS Foundation Trust
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- July 1, 2025
- Completion date
- April 30, 2026
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bacterial infections, chronic respiratory conditions, copd, pneumonia, respiratory exacerbation, viral infections